AstraZeneca and the EU both claim victory in the vaccine war | Business and Financial Issues

The court ruled on Friday that AstraZeneca had violated its agreement with the EU and ordered it to pay 80.2 million vaccinations to the EU by September 27 – at least 120 EU candidates by the end of June.

A Belgian court ruled Friday that the coronavirus vaccine manufacturer AstraZeneca had committed “serious violations” of its alliance with the European Union amid a major war over reproductive issues that has tarnished the company’s reputation.

The court ordered AstraZeneca to pay $ 80.2 million to the EU from the date of the agreement until September 27.

But the Anglo-Sweden company said it had won, saying that was a small amount compared to the 120 million standards set by the EU’s largest branch, the European Commission, by the end of June. It also received court approval for it to face unprecedented challenges.

AstraZeneca was seen as an important pillar in the implementation of the EU vaccine. Its agreement with the committee predicted that 300 million units would be distributed for the first time, with a chance of another 100 million, but the pace of delivery would be much slower than the company originally thought.

“We are pleased with what the Court has ruled,” said Vice President Jeffrey Pott. “AstraZeneca has fully complied with its agreement with the European Commission and we will continue to look for urgent work to provide effective vaccines.”

The committee said it would win because the judge ordered the company to honor 15 million units by July 26, 20 million on August 23 and 15 million on September 27. of 10 euros ($ 12) at unpaid rates.

“This opinion confirms what the commission has done: AstraZeneca has not kept its promises. It is good to see that an independent judge is confirming this,” said European Commission President Ursula von der Leyen.

“This shows that our European vaccine is not only available to our citizens on a daily basis. It also shows that it was legally established,” he said in a statement.

AstraZeneca’s image has been frustrated by the decline in its vaccine design, but while the EU is not satisfied with the speed of shipments, the agency is also promoting the company’s shotgun as a complete protection against coronavirus.

Finally, AstraZeneca is expected to meet the court’s mandate easily. It had already given a dose of 30 million by the end of March. From March to June, it provided another 40 million doses. This leaves them with more than $ 10.80.2 million to pay by September 27th.

Two more visits are scheduled for September if the Commission is still unsatisfied.

From the outset, the agency said it had established emergency legal procedures, which began in the Brussels First Court last month, only to find the vaccine that EU countries had promised.

It blamed AstraZeneca for misconduct in providing a shot to other countries, especially the United Kingdom, and said the company had to use its position in the UK to help achieve EU success.

But AstraZeneca said the difficulties in developing and distributing the vaccine would not be the same as the one-century epidemic, and that its UK location should be used in partnership with the British government.

In its 67-page decision, the court ruled that the company could not use all available means, including Oxford Biomedica and Halix in the UK, to meet EU deadlines. This can be seen as an attempt to make the most of the agreement.

In a statement, AstraZeneca said “it now hopes to resume its partnership with the European Commission to help combat the epidemic in Europe”.

Although donations will continue this year, the council has already decided not to renew its partnership with the company.